Quipt Home Medical (NASDAQ:QIPT) reached a definitive milestone in its transition to a private entity on Thursday, receiving a final order from the Supreme Court of British Columbia approving its previously announced plan of arrangement.
Under the terms of the agreement, affiliates of Kingswood Capital Management and Forager Capital Management will acquire all outstanding shares of the Cincinnati-based respiratory care provider for $3.65 per share in cash.
The deal, which values the company at approximately $260 million including debt, represents a 162% premium to Quipt’s unaffected share price in May 2025.
The court's approval follows an overwhelming shareholder vote on March 3, where 98.9% of cast ballots favored the acquisition.
With the final substantive legal hurdle cleared, the transaction is expected to close on or about March 16, 2026.
Upon completion, Quipt will be delisted from both the NASDAQ and the Toronto Stock Exchange (TSX) and will cease its status as a reporting issuer.
The move marks the conclusion of a high-profile year for Quipt, which recently integrated the $60 million Hart Medical Equipment acquisition while navigating a protracted buyout negotiation with Forager Capital.